Nesina 6.25 mg

Nesina 6.25 mg tablets contain alogliptin (alogliptin benzoate), a medication used to manage blood sugar levels in adults with type 2 diabetes. This oral tablet is designed to be taken as part of a comprehensive diabetes management plan.

Nesina 6.25 mg tablets are primarily used to help control blood sugar levels in adults with type 2 diabetes. This medication works by increasing the levels of incretin hormones, which help the pancreas release insulin in response to meals. It is often used alongside diet and exercise to manage diabetes effectively. People often ask, 'What is Nesina used for?' and the answer is that it is used to improve glycemic control in adults with type 2 diabetes.

Common effects of Nesina 6.25 mg tablets may include headache, nasal congestion, and upper respiratory tract infection. Some individuals might experience gastrointestinal issues such as nausea or diarrhea. These effects vary from person to person and are not experienced by everyone who takes the medication.

Nesina 6.25 mg tablets should be handled with care. It is important to follow the advice of a healthcare provider regarding its use. Patients with a history of pancreatitis or severe kidney problems should discuss their medical history with a healthcare professional before starting this medication. Always store the tablets in a cool, dry place away from direct sunlight.

Nesina 6.25 mg tablets may interact with certain medications, including other diabetes drugs, CYP inhibitors, and some antibiotics. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect blood sugar levels.